M. Marina

Differential expression of centrosome regulators in Her2+ breast cancer cells versus non-tumorigenic MCF10A cells

H. Saavedra, Mi-Young Lee, M. Marina, 2014, Cell Division.

The study of p 53 and p 16 immunoexpression in serous borderline and malignant ovarian tumors

A. Stepan, C. Simionescu, D. Mogo, 2012 .

The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cells

J. Padmanabhan, S. Chellappan, H. Saavedra, 2021, Scientific Reports.

Nek2 and Plk4: prognostic markers, drivers of breast tumorigenesis and drug resistance.

H. Saavedra, M. Marina, 2014, Frontiers in bioscience.

Plk 4 : prognostic markers , drivers of breast tumorigenesis and drug resistance

H. Saavedra, M. Marina, 2014 .

The scaffold protein MEK Partner 1 is required for the survival of estrogen receptor positive breast cancer cells

S. Conrad, Limin Wang, M. Marina, 2012, Cell Communication and Signaling.

The scaffold protein MEK Partner 1 is required for the survival of estrogen receptor positive breast cancer cells

S. Conrad, Limin Wang, M. Marina, 2012, Cell Communication and Signaling.